Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 Kip1 -independent pathway

By Castro C.   Campistol J.M.   Sancho D.   Sanchez-Madrid F.   Casals E.   Andres V.  

Atherosclerosis, Vol. 172, Iss. 1, 2004-01 ,pp. : 31-38

Elsevier

Access to resources Recommend Favorite

Intramuscular gene transfer of interleukin-10 cDNA reduces atherosclerosis in apolipoprotein E-knockout mice

By Namiki M.   Kawashima S.   Yamashita T.   Ozaki M.   Sakoda T.   Inoue N.   Hirata K.-I.   Morishita R.   Kaneda Y.   Yokoyama M.  

Atherosclerosis, Vol. 172, Iss. 1, 2004-01 ,pp. : 21-29

Elsevier

Access to resources Recommend Favorite

BubR1 Insufficiency Results in Decreased Macrophage Proliferation and Attenuated Atherogenesis in Apolipoprotein E‐Deficient Mice

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 9, 2016-09 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation

By Calkin A.   Giunti S.   Sheehy K.   Chew C.   Boolell V.   Rajaram Y.   Cooper M.   Jandeleit-Dahm K.  

Diabetologia, Vol. 51, Iss. 9, 2008-09 ,pp. : 1731-1740

Springer Publishing Company

Access to resources Recommend Favorite

Normal platelet reactivity in apolipoprotein E (apo E)-deficient mouse

By Nofer Jerzy-Roch   Brodde Martin   Herminghaus Grażyna   Seedorf Udo   Assmann Gerd   Kehrel Beate E.  

Platelets, Vol. 17, Iss. 7, 2006-11 ,pp. : 498-500

Informa Healthcare

Access to resources Recommend Favorite